STI571 (GLIVEC) induced hematologic, cytogenetic and molecular remission in a cml patient relapsing with accelerated phase after allogeneic stem cell transplantation.
Consoli
Ugo
U
Division of Haematology with Bone Marrow Transplantation, University of Catania, Italy. ugo.consoli@tin.it
Milone
Giuseppe
G
Guido
Giulia
G
Consoli
Carla
C
Palumbo
Giuseppe A
GA
Giustolisi
Rosario
R
D000970:Antineoplastic Agents / Q000008:administration & dosage; D001549:Benzamides; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*; D012074:Remission Induction / Q000379:methods; D016879:Salvage Therapy; D014184:Transplantation, Homologous
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate